RxNorm Names
DIMENHYDRINATE tablet
[Qualitest Pharmaceuticals]
Permanent Link:
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b4e1e0e9-a7cf-4c10-9e1b-0f4110be0767| Category | DEA Schedule | Marketing Status |
|---|---|---|
| HUMAN OTC DRUG LABEL | OTC monograph final |
NOTE:MOST OTC DRUGS ARE NOT REVIEWED AND APPROVED BY FDA, HOWEVER THEY MAY BE MARKETED IF THEY COMPLY WITH APPLICABLE REGULATIONS AND POLICIES. FDA HAS NOT EVALUATED WHETHER THIS PRODUCT COMPLIES.
Uses for prevention and treatment of these symptoms associated with motion sickness:
- nausea
- vomiting
- dizziness
Ask a doctor before use if you have
- a breathing problem such as emphysema or chronic bronchitis
- glaucoma
- difficulty in urination due to enlargement of the prostate gland
When using this product
- marked drowsiness may occur
- alcohol, sedatives and tranquilizers may increase drowsiness
- avoid alcoholic drinks
- be careful when driving a motor vehicle or operating machinery
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222).
Directions
- to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity
- to prevent or treat motion sickness, use the following dosing
|
adults and children |
1-2 tablets every 4-6 hours; not more than |
|
children 6 years to |
1/2-1 tablet every 6-8 hours; not more than |
|
children 2 years to |
1/4-1/2 tablet every 6-8 hours; not more than |
Other information
store at 15° to 30°C (59° to 86°F)
You may report serious side effects to: 130 Vintage Drive, Huntsville, AL 35811.
| DIMENHYDRINATE
dimenhydrinate tablet |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
| Labeler - Qualitest Pharmaceuticals (011103059) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| Vintage Pharmaceuticals-Huntsville | 825839835 | MANUFACTURE(0603-3327) | |
Revised: 12/2012
Document Id: ec450ba6-f03d-4820-8dbe-0a8e0227ce26
Set id: b4e1e0e9-a7cf-4c10-9e1b-0f4110be0767
Version: 2
Effective Time: 20121221
Qualitest Pharmaceuticals
Review RxNorm Normal Forms